Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2200 (LINC02200)

Target
LINC02200
Molecular classification
Other, long intergenic non-coding RNA, lincRNA
01

Overview

LINC02200 (long intergenic non-protein coding RNA 2200) is a human RNA gene classified as a lincRNA, meaning it is an autonomously transcribed, non-coding RNA of more than 200 nucleotides that does not overlap any protein-coding gene[3][1][5]. The genomic locus is identified in NCBI Gene (102467214) and Ensembl (ENSG00000250358)[3].\n\nlincRNAs as a class are known to regulate gene expression, chromatin structure, and genome architecture, sometimes acting as enhancers or scaffolds[1][7]. However, there is currently no published information indicating that LINC02200 itself has any characterized biological function, disease relevance, interaction with drugs, or utility as a diagnostic or therapeutic biomarker[3][1][5]. Thus, LINC02200 is not considered a therapeutic target. The gene has not been described as a receptor, enzyme, transporter, or transcription factor, and its aliases (e.g., RP11-159K7.2) do not refer to protein products or any established functional role[3].\n\nOther lincRNAs (like LINC00665 or XIST) have established roles in disease and cell regulation, but LINC02200 does not yet have functional annotation in the literature[1][2][3][5].\n\nShould new data emerge characterizing this transcript’s functions, disease associations, or targetability, molecular and clinical information should be updated accordingly. At present, LINC02200 is a poorly annotated non-coding RNA locus with no clear role in human biology or disease.

Other names
RP11-159K7.2LINC02200

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2200 (LINC02200).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2200 (LINC02200).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call